Remeron Soltab

This page contains recent news articles, when available, and an overview of Remeron Soltab but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Remeron Soltab
(when available)

Pharmacology and use:
Mirtazapine, an antidepressant of the piperazinoazepine class, is a tetracyclic compound with an anxiolytic effect. Mirtazapine has fewer ADRs than tricyclic antidepressants and is better tolerated. Selective blockade of specific serotonin receptors by mirtazapine likey minimizes side effects typical of other antidepressants. For the treatment of major depressive disorder

Mechanism Of Action:
Mirtazapine acts as an antagonist at central pre-synaptic alpha(2)-receptors, inhibiting negative feedback to the presynaptic nerve and causing an increase in NE release. Blockade of heteroreceptors, alpha(2)-receptors contained in serotenergic neurons, enhances the release of 5-HT, increasing the interactions between 5-HT and 5-HT1 receptors and contributing to the anxiolytic effects of mirtazapine. Mirtazapine also acts as a weak antagonist at 5-HT1 receptors and as a potent antagonist at 5-HT2 (particularly subtypes 2A and 2C) and 5-HT3 receptors. Blockade of these receptors may explain the lower incidence of adverse effects such as anxiety, insomnia, and nausea. Mirtazapine also exhibits significant antagonism at H1-receptors, resulting in sedation. Mirtazapine has no effects on the reuptake of either NE or 5-HT and has only minimal activity at dopaminergic and muscarinic receptors.

News Articles on Mirtazapine

Fast-Dissolving Antidepressant, Remeron SolTab(R), Enhances …  -  Oct 10, 2005
Two-thirds of depressed patients prefer Remeron SolTab(R), a fast dissolving antidepressant tablet to the antidepressant's conventional tablet formulation. ... Medical News Today - Medical News Today (press release)

Mirtazapine (generic): remeron, remeron soltab (brand).(YOUR …  -  Jun 1, 2006
IMPORTANT SIDE EFFECTS: Dry mouth, drowsiness, fatigue, constipation, increased appetite/weight gain (about 7% of body weight), sleeplessness, agitation, ... Free with registration - Brown University Geriatric Psychopharmac... - AccessMyLibrary.com

Press Release: Mylan Announces Tentative FDA Approval for …  -  Feb 26, 2007
Remeron SolTab(R) Orally Disintegrating Tablets in the 45 mg strength ... AB-rated brand Remeron SolTab Orally Disintegrating Tablets from Organon. ... Pay-Per-View - PR Newswire - HighBeam Research

Article: ODT draft guidance is too strict, industry tells FDA.(Regulat...  -  Sep 1, 2007
Mirtazapine Orally Disintegrating Tablets is a Prasco "Authorized ... AB-rated brand Remeron SolTab Orally Disintegrating Tablets from Organon. Prasco has . ... Pay-Per-View - Pharmaceutical Processing - HighBeam Research

Article: Orally disintegrating alprazolam.(Products)(Brief Article)( …  -  Aug 1, 2005
Mirtazapine Orally Disintegrating Tablets is a Prasco "Authorized ... AB-rated brand Remeron SolTab Orally Disintegrating Tablets from Organon. Prasco has . ... Pay-Per-View - Family Practice News - HighBeam Research

Article: Selegiline safe, effective as adjunct for Parkinson's.(care...  -  May 1, 2006
Mirtazapine Orally Disintegrating Tablets is a Prasco "Authorized ... AB-rated brand Remeron SolTab Orally Disintegrating Tablets from Organon. Prasco has . ... Pay-Per-View - Clinical Psychiatry News - HighBeam Research

Article: Orally disintegrating alprazolam.(FYI)(Brief Article) -...  -  Apr 1, 2005
The drug, a generic version of Organon's anti-depressant Remeron SolTab, was developed by Par subsidiary ... Pharma Marketletter ... Pay-Per-View - Clinical Psychiatry News - HighBeam Research

Press Release: Barr's Subsidiary PLIVA Launches Ondansetron 4 mg and …  -  Dec 26, 2006
Remeron SolTab(R) Orally Disintegrating Tablets in the 45 mg strength ... AB-rated brand Remeron SolTab Orally Disintegrating Tablets from Organon. ... Pay-Per-View - PR Newswire - HighBeam Research

Aurobindo gets USFDA nod for Mirtazapine  -  Dec 14, 2005
Mirtazapine is the generic version of Organon's Remeron SolTab, and is prescribed for the treatment of major depressive disorder, the release added. Business Standard

Aurobindo Pharma gets USFDA nod to sell depression drug  -  Dec 16, 2005
Mirtazapine ODT is the generic version of Organon's Remeron SolTab and is indicated for the treatment of major depressive disorder. ... Hindu Business Line

FTC clears Eisai takeover of MGI Pharma.(News)(United States. Federal...  -  Feb 4, 2008
Remeron SolTab mirtazapine Organon Prasco Salagen pilocarpine MGI Pharma Alpharma (Purepac) Tambocor Flecainide 3M Mylan Terazol3 ... ... Pay-Per-View - Chain Drug Review - HighBeam Research

Barr Pharmaceuticals receives tentative approval while ID Biomedical ...  -  Jan 10, 2005
Laboratories unit received tentative Food and Drug Administration approval to market a generic version of Organon Inc.'s Remeron Soltab antidepressant. ... Free with registration - M2 Presswire - AccessMyLibrary.com

Drug/Medical Device  -  Mar 14, 2006
Remeron/Remeron SolTab (Mirtazapine), Depression, Somnolence, Nausea, Increased Appetite, Weight Gain, Dizziness, Dry Mouth, Constipation, Approved ... $70.00 - Revere Reports - Revere

Article: Teva Pharmaceuticals.(RX/GENERIC DRUGS--Profiles)(Company …  -  Sep 25, 2006
Chain Drug Review; October 25, 2004 ; 700+ words ... ... mg) and is AB-rated to Remeron SolTab ... The product is bioequivalent to Ovation Pharmaceuticals ... Pay-Per-View - Chain Drug Review - HighBeam Research

eCME Courses Now Available Free-of-Charge at Psychiatrymatters.MD  -  Nov 1, 2005
MD is supported by an educational grant from Organon, manufacturer of Remeron SolTab®, and its content is independently managed by the Current Medicine ... Medical News Today - Medical News Today (press release)

Laurence Downey.(appointments)(Brief Article) | Article from Chain...  -  Feb 27, 2006
Organon Inc. and Solvay Pharmaceuticals Inc. are copromoting the latter's Remeron SolTab, the first orally disintegrating tablet for the treatment of ... Pay-Per-View - Chain Drug Review - HighBeam Research

Par Pharmaceutical.(partner Amide Pharmaceutical gets license for …  -  Sep 26, 2005
Mirtazapine ODT is the generic version of Organon's Remeron SolTab and is indicated for the treatment of major depressive disorder. ... Free with registration - Drug Store News - AccessMyLibrary.com

FDA Safety Labeling Changes: CombiPatch, Antidepressants  -  Mar 23, 2005
...made by Synthon Pharmaceuticals, Ltd.); mirtazapine orally disintegrating tablets and tablets (Remeron SolTab and Remeron, made by Organon, Inc.); ... Medscape

INDIAN NEWSPAPER HIGHLIGHTS - DEC 16, 2005.  -  Dec 16, 2005
Mirtazapine ODT is the generic version of Organon's Remeron SolTab and is indicated for the treatment of major depressive disorder. ... Free with registration - AsiaPulse News - AccessMyLibrary.com

新技术掀起医è?¯é?©å‘½æ€§æµªæ½®  -  Feb 22, 2006
...米氮平ODT是欧加农公å?¸å¼€å?‘的抗抑éƒ?剂,商å“?å??为Remeron SolTab。在美国,米氮平ODT 的年销售é¢?约达9000万美元。 2ã€?地洛他定5mgODT:先ç?µè‘†é›…å…¬å?¸äºŽ2003å¹´6月在美国 ... 新浪网

Actavis' Subsidiary Amide Receives FDA approval for Mirtazapine ODT  -  Sep 5, 2005
30 mg and 45Mirtazapine ODT is the generic version of Organon's Remeron SolTab(R) and is indicated for the treatment of major depressive disorder. ... primezone.com

Press Release: Barr Pharmaceuticals receives tentative approval while...  -  Jan 10, 2005
Laboratories unit received tentative Food and Drug Administration approval to market a generic version of Organon Inc.'s Remeron Soltab antidepressant. ... Pay-Per-View - M2 Presswire - HighBeam Research

Drug Approvals  -  Sep 9, 2005
Mirtazapine ODT is the generic version of Organon's Remeron SolTab and is indicated for the treatment of major depressive disorder. ... Pay-Per-View - Drug Industry Daily - Factiva, from Dow Jones

Drug Development; Tentative approval granted for Mirtazapine orally …  -  Feb 7, 2005
...(FDA) for its generic version of Organon, Inc.'s Remeron Soltab Orally Disintegrating Tablets, 45 mg (Mirtazapine Orally Disintegrating Tablets). ... Pay-Per-View - Biotech Business Week - Factiva, from Dow Jones

Drug Development; Tentative approval granted for Mirtazapine orally …  -  Feb 13, 2005
...(FDA) for its generic version of Organon, Inc.'s Remeron Soltab Orally Disintegrating Tablets, 45 mg (Mirtazapine Orally Disintegrating Tablets). ... Pay-Per-View - Medical Letter on the CDC & FDA - Factiva, from Dow Jones

New generics.  -  Oct 10, 2005
This generic version of Remeron SolTab, from Organon, will be used for treating depression. American Pharmaceutical Partners, Schaumburg, Ill., ... $9.94 - Drug Topics - Alacra Store

New generics.  -  Feb 21, 2005
Mirtazapine orally disintegrating tablets, a version of Organon's Remeron Soltab Orally Disintegrating Tablets, 45 mg, are indicated for the treatment of ... $9.94 - Drug Topics - Alacra Store

Article: Correction.(Correction Notice) - Journal of Neuroscience...  -  Aug 1, 2005
Remeron Soltab Tricyclic antidepressants (TCAs) Amitriptyline -- Desipramine Norpramin Doxepin Sinequan ... scored; ext-rel = extended-release: del-rel ... Pay-Per-View - Journal of Neuroscience Nursing - HighBeam Research

Press Release: Par Pharmaceutical's Partner Receives Final Approval...  -  Sep 1, 2005
The product was developed by Par's wholly-owned subsidiary, Kali Laboratories, Inc. Mirtazapine ODT is the generic version of Organon's Remeron SolTab(R) ... Pay-Per-View - PR Newswire - HighBeam Research

Drug Development; Tentative approval granted for Mirtazapine orally …  -  Feb 11, 2005
...(FDA) for its generic version of Organon, Inc.'s Remeron Soltab Orally Disintegrating Tablets, 45 mg (Mirtazapine Orally Disintegrating Tablets). ... Pay-Per-View - Drug Week - Factiva, from Dow Jones

Drug Approvals  -  Sep 21, 2005
Mirtazapine ODT is the generic version of Organon's Remeron SolTab and is indicated for the treatment of major depressive disorder. ... Pay-Per-View - Generic Line - Factiva, from Dow Jones

Par receives go-ahead for mirtazapine ODT.(Par Pharmaceutical Inc., …  -  Sep 12, 2005
The drug, a generic version of Organon's anti-depressant Remeron SolTab, was developed by Par subsidiary Kali Laboratories and is available in three dosage ... $4.95 - Pharma Marketletter - ECNext

Pharmaceutical: top 50 packages.(TOP 200 PACKAGERS)(Illustration) | …  -  Jul 1, 2005
Restasis; Alphagan P; Lumigan; Acular LS 27Organon InternationalRemeron/Remeron SolTab; (25) Inc., Sub. of Akzo Nobel Puregon/ Follistim; Oss, ... Pay-Per-View - Food & Drug Packaging - HighBeam Research

Pharmaceutical: top 50 packages.(TOP 200 PACKAGERS)(Illustration)  -  Jul 1, 2005
Restasis; Alphagan P; Lumigan; Acular LS 27 Organon International Remeron/Remeron SolTab; (25) Inc., Sub. of Akzo Nobel Puregon/ Follistim; Oss, ... $4.95 - Food & Drug Packaging - ECNext

Sveikas žmogus  -  Oct 12, 2005
· Ar pastebÄ—jote, kokios galingos mÅ«sų mintys? Dar senovÄ—s filosofai įrodÄ—: gyvename ir jauÄ?iamÄ—s taip, kaip mÄ…stome. Kaip iÅ¡mokti eiti per triukÅ¡mÄ… ir bÅ«ti ... Sveikas žmogus

Brand Names/Synonyms:
Remeron Soltab is also known by the following brand names and/or synonymsCHEMBANK1791; Mepirzepine; Mirtazapina [Inn-Spanish]; Mirtazapine; Mirtazapine [Usan:Ban:Inn]; Mirtazapinum [Inn-Latin]; Mirtazepine; ORG 3770; Olsalazine; Org-3770; Remeron; Remeron Soltab; Soltabt

Drug Category:
Remeron Soltab is categorized under the following by the FDA: Adrenergic alpha-Antagonists; Antidepressive Agents, Tricyclic; Histamine H1 Antagonists; ATC:N06AX11

Dosage Forms:
TABLET; TABLET (ORALLY DISINTEGRATING)

Absorption:
Rapid and complete, but, due to first-pass metabolism, absolute bioavailability is 50%.

Interactions:
[an error occurred while processing this directive]



Chemical IUPAC Name:
1,2,3,4,10,14b-hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy